Alphina Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.02M
- Investors
-
6
Alphina Therapeutics General Information
Description
Developer of a healthcare technology designed for the treatment of a range of solid tumor indications. The company offers approaches to identify and characterize altered metabolic states, metabolism, and flux for selective tumor targeting over normal tissue, enabling biomarkers to develop new classes of drugs and therapies that target defects in cancer.
Contact Information
Website
www.alphinatx.comCorporate Office
- Elm City Bioscience Center
- 55 Church Street
- New Haven, CT 06510
- United States
Corporate Office
- Elm City Bioscience Center
- 55 Church Street
- New Haven, CT 06510
- United States
Alphina Therapeutics Timeline
Alphina Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 15-Apr-2026 | $3.02M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 20-Mar-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 15-Oct-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Sep-2021 | $40M | $41.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 06-Apr-2021 | $1.63M | $1.63M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Alphina Therapeutics Comparisons
Industry
Financing
Details
Alphina Therapeutics Competitors (70)
One of Alphina Therapeutics’s 70 competitors is Sitryx, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sitryx | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Byondis | Corporation | Nijmegen, Netherlands | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA |
Alphina Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alphina Therapeutics Patents
Alphina Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026143213-A1 | Heteroaryl compounds and their use in treating diseases such as cancer | Pending | 27-Dec-2024 | ||
| US-20260183268-A1 | Heteroaryl compounds and their use in treating medical conditions | Pending | 27-Dec-2024 | ||
| AU-2024382540-A1 | Anti-naprt antibodies and methods of use | Pending | 14-Nov-2023 | ||
| EP-4808986-A2 | Anti-naprt antibodies and methods of use | Pending | 14-Nov-2023 | ||
| WO-2025106716-A2 | Anti-naprt antibodies and methods of use | Inactive | 14-Nov-2023 | C07K16/40 |
Alphina Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alphina Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yale Ventures | Accelerator/Incubator | |||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Osage University Partners | Venture Capital | Minority | ||
| Connecticut Innovations | Venture Capital | Minority |
Alphina Therapeutics FAQs
-
When was Alphina Therapeutics founded?
Alphina Therapeutics was founded in 2018.
-
Where is Alphina Therapeutics headquartered?
Alphina Therapeutics is headquartered in New Haven, CT.
-
What is the size of Alphina Therapeutics?
Alphina Therapeutics has 12 total employees.
-
What industry is Alphina Therapeutics in?
Alphina Therapeutics’s primary industry is Drug Discovery.
-
Is Alphina Therapeutics a private or public company?
Alphina Therapeutics is a Private company.
-
What is Alphina Therapeutics’s current revenue?
The current revenue for Alphina Therapeutics is .
-
How much funding has Alphina Therapeutics raised over time?
Alphina Therapeutics has raised $49.6M.
-
Who are Alphina Therapeutics’s investors?
Yale Ventures, Alexandria Venture Investments, Canaan Partners, Osage University Partners, and Connecticut Innovations are 5 of 6 investors who have invested in Alphina Therapeutics.
-
Who are Alphina Therapeutics’s competitors?
Sitryx, Byondis, Intellia Therapeutics, Ayala Pharmaceuticals, and NGM Biopharmaceuticals are some of the 70 competitors of Alphina Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
